According to a post on the FDA’s website, Puma Biotechnology’s alisertib was granted orphan designation in the treatment of small cell lung cancer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PBYI:
